"/>

U.S. reproductive health companies eye China's huge ART market

Source: Xinhua    2018-05-08 04:00:37

NEW YORK, May 7 (Xinhua) -- U.S. reproductive health companies are keen to venture into the "huge and very underserved" Assisted Reproductive Technology (ART) market in China whose infertile population will reach 40 million by 2020.

China presents a unique opportunity for U.S. reproductive health companies as infertility patients in the country are expected to reach 40 million over the next two years, said Dr. Kevin Doody, Chairman of the Society of Assisted Reproductive Technology (SART), at a recent reception hosted by the Chinese Medical Doctor Association (CMDA) and Global Fertility & Genetics (GFG) Inc. in New York City.

SART has already partnered with CMDA in an initiative to advance the standards of practice of ART and related services in China, he said.

The primary organization of professionals dedicated to the practice of ART in the United States has also entered into an agreement with Shanghai University of Traditional Chinese Medicine in finding ways of integrating eastern and western approaches for better ART care, Doody said.

"Our intention is to have GFG and INVO Bioscience to partner with an exclusive agreement in the Hainan," said Katie Karloff, Co-founder of INVO Bioscience, in an interview with Xinhua after the reception. "The exclusivity will be for 3 years initially and we are working out milestone for continued exclusivity."

"As you know, the China market is huge and very underserved. INVO will provide initial devices free to get started and get some clinical data," Karloff said.

Karloff said Doody will be training the physicians and embryologists from GFG in New York so that they will be prepared to train physicians and embryologists in Hainan, the southernmost Chinese island.

Hainan Boao Lecheng International Medical Tourism Pilot Zone, the first of its kind in China, is the best place for the potential collaboration and communication between Chinese and U.S. medical institutions in the field of reproductive health, said Dr. Bo Hu, Chairman of the CMDA Health Management, and Health Insurance Professional committee, Chairman of the Ciming Boao International Hospital.

Hu also extended his welcome to U.S. ART companies to attend the 5th China (Beijing) International Trade Fair in Services (CIFTIS), to be held in Beijing from May 28 to June 1, to explore cross-border collaboration.

Boao Lecheng pilot zone is a demonstration project for China's healthcare reform. It enjoys nine special preferential policies, such as special permission for importing medical technology, medical equipment and medicine, under which foreign companies will be able to set up medical organizations and foreign medications can enjoy a special import tariff.

The pilot zone, six kilometers from the site of the Boao Forum for Asia, covers an area of 20 square kilometers and is expected to be completed in five years. About 27 projects have been completed or are under construction.

Editor: yan
Related News
Xinhuanet

U.S. reproductive health companies eye China's huge ART market

Source: Xinhua 2018-05-08 04:00:37

NEW YORK, May 7 (Xinhua) -- U.S. reproductive health companies are keen to venture into the "huge and very underserved" Assisted Reproductive Technology (ART) market in China whose infertile population will reach 40 million by 2020.

China presents a unique opportunity for U.S. reproductive health companies as infertility patients in the country are expected to reach 40 million over the next two years, said Dr. Kevin Doody, Chairman of the Society of Assisted Reproductive Technology (SART), at a recent reception hosted by the Chinese Medical Doctor Association (CMDA) and Global Fertility & Genetics (GFG) Inc. in New York City.

SART has already partnered with CMDA in an initiative to advance the standards of practice of ART and related services in China, he said.

The primary organization of professionals dedicated to the practice of ART in the United States has also entered into an agreement with Shanghai University of Traditional Chinese Medicine in finding ways of integrating eastern and western approaches for better ART care, Doody said.

"Our intention is to have GFG and INVO Bioscience to partner with an exclusive agreement in the Hainan," said Katie Karloff, Co-founder of INVO Bioscience, in an interview with Xinhua after the reception. "The exclusivity will be for 3 years initially and we are working out milestone for continued exclusivity."

"As you know, the China market is huge and very underserved. INVO will provide initial devices free to get started and get some clinical data," Karloff said.

Karloff said Doody will be training the physicians and embryologists from GFG in New York so that they will be prepared to train physicians and embryologists in Hainan, the southernmost Chinese island.

Hainan Boao Lecheng International Medical Tourism Pilot Zone, the first of its kind in China, is the best place for the potential collaboration and communication between Chinese and U.S. medical institutions in the field of reproductive health, said Dr. Bo Hu, Chairman of the CMDA Health Management, and Health Insurance Professional committee, Chairman of the Ciming Boao International Hospital.

Hu also extended his welcome to U.S. ART companies to attend the 5th China (Beijing) International Trade Fair in Services (CIFTIS), to be held in Beijing from May 28 to June 1, to explore cross-border collaboration.

Boao Lecheng pilot zone is a demonstration project for China's healthcare reform. It enjoys nine special preferential policies, such as special permission for importing medical technology, medical equipment and medicine, under which foreign companies will be able to set up medical organizations and foreign medications can enjoy a special import tariff.

The pilot zone, six kilometers from the site of the Boao Forum for Asia, covers an area of 20 square kilometers and is expected to be completed in five years. About 27 projects have been completed or are under construction.

[Editor: huaxia]
010020070750000000000000011105521371623701
网信快3 大发app 凤凰彩票app 乐发iv游戏平台 凤凰彩票大厅 乐发彩票 乐发彩票app下载 大发彩票 乐发v官网 乐发lll 乐发lv入口 乐发iv首页 乐发ll登录 凤凰彩票大厅 乐发官网 乐发ii下载入口 乐发ll 乐发v平台 乐发v官网 乐发lll 乐发lv入口 乐发iv首页 乐发ll登录 乐发lv 乐发lll安装 乐发lv 乐发登录入口 乐发iv游戏平台 凤凰彩票登录 网信彩票 彩神 彩神彩票官方网站 彩神彩票官网首页 彩神官方app下载安卓版 凤凰彩票登录 彩神v3 凤凰彩票app下载 彩神官方app下载安卓版 网信快三 一分快3 快三彩票购彩平台 凤凰彩票官方 快3官网 网信彩票 快3app 网信彩票平台 百姓彩票平台 网信平台官网 快3app下载 百姓彩票 每日彩票 快3app 百姓彩票 每日彩票 快3app 百姓彩票平台 幸运5分彩快3 快3彩票app下载 百姓彩票网站网址 大发10分PK10 快3下载 网信彩票平台 网信平台官网 快3彩票官网app 凤凰彩票官方 彩神彩票 大发10分PK10 彩神v3 大发彩票app下载 百姓彩票网站网址 彩神购彩平台 每日彩票 官方正规快三彩票平台 彩神彩票购彩平台 百姓彩票 凤凰彩票购彩平台 凤凰彩票app下载 彩神官方app下载安卓版 网信快三 一分快3 快三彩票购彩平台 凤凰彩票官方 彩神彩票 大发10分PK10 彩神v3 凤凰彩票登录 乐发lv 乐发∨Il 百姓彩票网站网址 乐发彩票 乐发彩票官方网站 乐发lll安装 百姓彩票网站网址 凤凰彩票app下载 大发10分PK10 乐发2 乐发app 凤凰彩票 大发彩票app 乐发登录入口 乐发ll登录 乐发v官网 乐发官网 大发彩票app下载 凤凰彩票购彩平台 彩神彩票 官方正规快三彩票平台 一分快3 百姓彩票网站网址 凤凰彩票app下载 大发10分PK10 乐发2 乐发app 凤凰彩票 大发彩票app 乐发登录入口 乐发ll登录 乐发v官网 乐发官网 大发彩票app下载 凤凰彩票购彩平台 彩神彩票 官方正规快三彩票平台 1分快三平台 百姓彩票平台 凤凰彩票登录 幸运5分彩快3 彩神 乐发彩票 乐发 大发彩票 乐发iv游戏平台 乐发lv 乐发lll 乐发ii下载入口 乐发彩票官方网站 凤凰彩票官方网站 凤凰快3 彩神彩票官网首页 1分快三平台 百姓彩票平台 凤凰彩票登录 幸运5分彩快3 彩神 乐发彩票 乐发 大发彩票 乐发iv游戏平台 乐发lv 凤凰彩票app 乐发app 网信彩票平台 网信彩票平台 乐发iv游戏平台 凤凰彩票app 乐发lv 乐发彩票app下载 凤凰彩票app 网信彩票平台 乐发彩票app下载 乐发lv 乐发app 大发彩票安卓下载 大发彩票安卓下载 大发彩票 乐发彩票app下载 网信彩票平台 乐发iv游戏平台 彩神彩票 乐发彩票中心 极速快3彩票平台 人人快三凤凰 大发彩票app 大发彩票大全 乐发彩票 彩神彩票官方网站 乐发app 酷天堂彩票平台 凤凰彩票app下载 凤凰彩票大厅 凤凰彩票app 极速快3彩票平台 凤凰彩票 凤凰快3 乐发ll官网 乐发彩票中心 正规快三送彩金平台 凤凰彩票官方 乐发ll 乐发 网信彩票 彩神彩票 彩神彩票官方网站 大发彩票app 网信彩票用户 百姓快三 百姓彩票平台 乐发lv 乐发彩票app下载 彩信平台 网信彩票 乐发彩票官方网站 乐发∨Il 人人快三凤凰 凤凰彩票 凤凰快3 乐发ll官网 乐发彩票中心 正规快三送彩金平台 凤凰彩票官方 乐发ll 乐发 网信彩票 彩神彩票 彩神彩票官方网站 人人快三凤凰 乐发彩票 彩神彩票 乐发iv游戏平台 乐发彩票 大发彩票中心 凤凰彩票登录 凤凰彩票app 彩神彩票 大发彩票 乐发ll 大发彩票app 凤凰快3 凤凰彩票 彩神彩票 乐发ll 凤凰彩票 乐发lll 凤凰彩票大厅 网信彩票 彩神彩票 乐发lv 快盈彩票 乐发彩票官方网站 盈彩网投资平台 大发官网 一分时时彩 乐发lv 快3平台 凤凰快3 乐发ll 全民彩票 乐发彩票官方网站 百姓彩票 乐发彩票 大发彩票 极速快3 乐发app 大发官网 乐发lll 快3平台 凤凰快3 乐发ll 全民彩票 乐发彩票官方网站 百姓彩票 乐发彩票 大发彩票 极速快3 乐发app 彩神iv 大发彩票app 大小单双平台 一分pk10 乐发lv 快盈彩票 乐发官网 快彩彩票 百姓彩票 凤凰彩票大厅 网信彩票 乐发彩票中心 网信快3 乐发 彩神xl 三分快3 大发彩票 大发官网 乐发lll 快3平台 凤凰快3 乐发ll 全民彩票 乐发彩票官方网站 百姓彩票 乐发彩票 乐发彩票官方网站 大发彩票 乐发 分分快3 彩神vl 55世纪 55世纪 凤凰快3 乐发彩票 乐发lv welcome凤凰彩票 乐发ll 1分快3 彩神 彩神ll 1分快3官网 1分快3的平台 welcome凤凰彩票 三分快3 彩神x 彩神vl 凤凰彩票 彩神xl 大发彩票 凤凰彩票大厅 乐发官网 乐发ll 乐发lll 乐发lv 大发彩票app 大发彩票 乐发 乐发彩票 乐发彩票中心 凤凰快3 乐发彩票 彩神xl 腾讯快3 大发彩票 彩神xl 大发彩票 乐发彩票 大发彩票app 快3平台 乐发 1分快3 乐发彩票 彩神x 凤凰快3 彩神xl 彩吧助手 大发彩票app 快3平台 大发排列3 彩神iv 彩神vl 乐发IV 彩神x 一分pk10 大发排列3 乐发lv 快3彩票 乐发app下载 三分快3 快三平台助手 乐发彩票ll 彩神iv 乐发lll下载 盈彩网投资平台 乐发Ⅲ 一分pk10 凤凰彩票 乐发Vll 大发官网 乐发ll 大发彩票 乐发1 凤凰快3 彩神vl 乐发lx 百姓彩票 乐发VI 彩神x 乐发IV 极速快3 乐发 凤凰快3 网信快3 乐发lv 快3彩票 乐发app下载 三分快3 快三平台助手 乐发彩票ll 彩神iv 乐发lll下载 盈彩网投资平台 乐发Ⅲ 凤凰彩票大厅 乐发lv 乐发lv 乐发lv 凤凰彩票 大发彩票 大发彩票 凤凰彩票 乐发lv 凤凰彩票 凤凰彩票 乐发lv 乐发ll 凤凰彩票app下载 凤凰彩票 凤凰彩票 乐发lv 乐发ll 凤凰彩票app下载 凤凰彩票 凤凰彩票 乐发lv 彩神x 乐发 乐发ll 极速快3 乐发lv 乐发彩票中心 快3彩票 凤凰彩票大厅 彩神x 凤凰彩票app 分分快3 网信彩票 网盟彩票 凤凰彩票 百姓彩票 乐发 快彩彩票 乐发彩票 快3平台 百姓彩票 大小单双平台 凤凰快3 彩神xl 一分pk10 乐发lv 三分快3 大发彩票 乐发彩票 快3平台 百姓彩票 大小单双平台 凤凰快3 彩神xl 一分pk10 乐发lv 三分快3 大发彩票 极速快3 乐发ll 网信彩票 乐发lv 全民彩票 凤凰彩票app下载 快盈彩票 大发彩票app 大发官网 凤凰彩票 彩神iv 大发彩票 网信快3 凤凰彩票 百姓彩票